Free Trial

EKF Diagnostics (LON:EKF) Trading Up 10.8% - Still a Buy?

EKF Diagnostics logo with Medical background

Shares of EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) traded up 10.8% on Saturday . The company traded as high as GBX 26.60 ($0.33) and last traded at GBX 26.60 ($0.33). 1,224,627 shares traded hands during mid-day trading, an increase of 205% from the average session volume of 401,221 shares. The stock had previously closed at GBX 24 ($0.30).

EKF Diagnostics Price Performance

The stock has a fifty day moving average of GBX 26.38 and a 200 day moving average of GBX 27.92. The stock has a market cap of £120.69 million, a price-to-earnings ratio of 2,660.00 and a beta of 0.57. The company has a debt-to-equity ratio of 1.78, a current ratio of 4.59 and a quick ratio of 1.77.

About EKF Diagnostics

(Get Free Report)

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.

Featured Stories

Should you invest $1,000 in EKF Diagnostics right now?

Before you consider EKF Diagnostics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EKF Diagnostics wasn't on the list.

While EKF Diagnostics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines